Description: enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Home Page: www.envveno.com
70 Doppler
Irvine,
CA
92618
United States
Phone:
949 261 2900
Officers
| Name | Title |
|---|---|
| Mr. Robert A. Berman | CEO & Director |
| Mr. Craig Thomas Glynn | CFO, Treasurer & Secretary |
| Dr. Hamed Alavi Ph.D. | Senior VP & Chief Technology Officer |
| Dr. Marc H. Glickman M.D. | Senior VP & Chief Medical Officer |
| Mr. Warren Hancock | Co-founder |
| Ms. Sandy Prietto | Vice President of Marketing |
| Dr. Benedict Broennimann M.D. | Chief Medical Officer of Outside of United States |
| Mr. Andrew Cormack | Chief Commercial Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0972 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 31 |